RE:RE:RE:RE:RE:RE:RE:Bigger institutional investors are adding to their position 1st line for high grade ovarian cancer is Carboplatin with taxol. After a patient becomes platinum resistant, next up is either weekly taxol or doxorubicin, efficacy is equivalent but side effects are different. My wife's first line was 6 cycles of Carboplatin with Taxol. Second line was 5 cycles of Carboplatin with Taxol. Third line 8 cycles of Carboplatin with pegylated doxorubicin. (They allowed the Carboplatin because almost a year had passed since the last cycle of Carboplatin.) This is for high grade ( about 70% of ovarian cancer patients) . There are 3 other types of ovarian cancer. And many subtypes. Also, there now are maintenance treatments like Avastin and parp inhibitors, but they don't count as separate lines ot treatments.
qwerty22 wrote: "Also, it has been said here that docetaxel is indicated as a first line treatment in ovarian cancer but nothing is said about ovarian on the label for docetaxel (see link below). Anyone want to offer an explanation for that? "
It is doxorubicin that's the ovarian cancer drug. So relevant for th1904. I don't think docetaxel has ever been an ovarian cancer drug.